EXCiPACT asbl, a body implementing a third-party certification scheme, reports that Ashland's Aquarius plant site Wilmington, Delaware has recently been awarded an EXCiPACT Certificate from SGS Belgium, one of EXCIPACT's certification bodies.

The certificate demonstrates that Ashland's Aquarius plant site in Wilmington, Delaware manufactures pharmaceutical excipients according to the EXCiPACT good manufacturing practice (GMP) certifccation standard. Its scope covers the manufacturing, testing, and packaging of pharmaceutical excipients used as film coatings in pharmaceutical industry. Relevant products are of brand Aquarius.

EU and U.S. pharmaceutical regulations now require drug manufacturers to conduct either their own or commission third-party physical audits of all their starting material suppliers to demonstrate GMP and/or GDP (good distribution practive) compliance thus increasing the audit burden. <.p>

Source: EXCiPACT